Inventor · disambiguated record
Esther Chang
Also filed as: CHANG ESTHER · CHANG ESTHER H
22 granted patents·14 pending applications·351 citations·filing 1995–2024
95Inventor score
Files withUNIV GEORGETOWN14CHANG ESTHER H5SYNERGENE THERAPEUTICS INC5BOSTON SCIENT SCIMED INC4AVENTIS PHARMA GMBH2
Top patents by PatentIndex Score
36 records- 0192US7780882B2Simplified and improved method for preparing an antibody or an antibody fragment targeted immunoliposome for systemic administration of a therapeutic or diagnostic agentUNIV GEORGETOWN·Filed 2002·Granted Aug 24, 2010·35 cites·21 claims
- 0290US8865127B2Simplified and improved method for preparing an antibody or an antibody fragment targeted immunoliposome for systemic administration of a therapeutic or diagnostic agentCHANG ESTHER H·Filed 2010·Granted Oct 21, 2014·9 cites·70 claims
- 0388US8002789B2Stretch-resistant vaso-occlusive devices with flexible detachment junctionsSTRYKER CORP·Filed 2005·Granted Aug 23, 2011·59 cites·21 claims
- 0487US9486223B2Mechanically datachable vaso-occlusive deviceBOSTON SCIENT SCIMED INC·Filed 2015·Granted Nov 8, 2016·8 cites·16 claims
- 0586US8926650B2Mechanically detachable vaso-occlusive deviceQUE LIKE·Filed 2007·Granted Jan 6, 2015·45 cites·12 claims
- 0686US8617514B2Tumor-targeted nanodelivery systems to improve early MRI detection of cancerCHANG ESTHER H·Filed 2006·Granted Dec 31, 2013·4 cites·27 claims
- 0783US8834515B2Mechanically detachable vaso-occlusive deviceWIN THAZIN·Filed 2007·Granted Sep 16, 2014·43 cites·11 claims
- 0882US6749863B1Targeted liposome gene deliveryUNIV GEORGETOWN·Filed 1998·Granted Jun 15, 2004·62 cites·56 claims
- 0980US8956381B2Mechanically detachable vaso-occlusive deviceQUE LIKE·Filed 2007·Granted Feb 17, 2015·30 cites·8 claims
- 1080US8859274B2Antibody fragment-targeted immunoliposomes for systemic gene deliveryXU LIANG·Filed 2006·Granted Oct 14, 2014·3 cites·6 claims
- 1180US6803360B1Compositions and methods for reducing radiation and drug resistance in cellsUNIV GEORGETOWN·Filed 2000·Granted Oct 12, 2004·7 cites·32 claims
- 1278US9034330B2Preparation of antibody or an antibody fragment-targeted immunoliposomes for systemic administration of therapeutic or diagnostic agents and uses thereofCHANG ESTHER H·Filed 2007·Granted May 19, 2015·3 cites·47 claims
- 1377US9814465B2Mechanically detachable vaso-occlusive deviceBOSTON SCIENT SCIMED INC·Filed 2014·Granted Nov 14, 2017·7 cites·20 claims
- 1476US7479276B1Antibody fragment-targeted immunoliposomes for systemic gene deliverySYNERGENE THERAPEUTICS INC·Filed 2000·Granted Jan 20, 2009·9 cites·14 claims
- 1575US9034329B2Preparation of antibody or an antibody fragment-targeted immunoliposomes for systemic administration of therapeutic or diagnostic agents and uses thereofCHANG ESTHER H·Filed 2006·Granted May 19, 2015·1 cites·66 claims
- 1666US9878055B2Treatment for exposure to nerve agentUNIV GEORGETOWN·Filed 2014·Granted Jan 30, 2018·0 cites·27 claims
- 1765US11951167B2Targeted liposomesUNIV GEORGETOWN·Filed 2021·Granted Apr 9, 2024·0 cites·30 claims
- 1864US2008213223A1Systemic viral/ligand gene delivery system and gene therapySYNERGENE THERAPEUTICS INC·Filed 2007·Application pending·0 cites
- 1963US10668172B2Treatment for exposure to nerve agentUNIV GEORGETOWN·Filed 2017·Granted Jun 2, 2020·0 cites·20 claims
- 2063US2024366507A1Methods of Treating Neurologic DisordersSYNERGENE THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 2161US2014178296A1Tumor-targeted nanodelivery systems to improve early mri detection of cancerUNIV GEORGETOWN·Filed 2013·Application pending·0 cites
- 2260US6027892ACompositions and methods for reducing radiation and drug resistance in cellsCHANG ESTHER H·Filed 1997·Granted Feb 22, 2000·14 cites·12 claims
- 2359US2009191261A1Antibody fragment-targeted immunoliposomes for systemic gene deliverySYNERGENE THERAPEUTICS INC·Filed 2008·Application pending·0 cites
- 2459US2005063950A1Systemic viral/ligand gene delivery system and gene therapyUNIV GEORGETOWN·Filed 2004·Application pending·0 cites
- 2558US6723706B2Modified antisense nucleotides complementary to a section of the human Ha-ras geneAVENTIS PHARMA GMBH·Filed 1998·Granted Apr 20, 2004·12 cites·30 claims
- 2658US2014120157A1Targeted liposomesUNIV GEORGETOWN·Filed 2013·Application pending·0 cites
- 2757US2005020523A1Modified antisense nucleotides complementary to a section of the human haras geneAVENTIS PHARMA GMBH·Filed 2003·Application pending·0 cites
- 2851US2015252372A1Preparation of antibody or an antibody fragment targeted immunoliposomes for systemic administration of therapeutic or diagnostic agents and uses thereofUNIV GEORGETOWN·Filed 2015·Application pending·0 cites
- 2949US12274784B2Methods for reducing side effects of immunotherapySYNERGENE THERAPEUTICS INC·Filed 2019·Granted Apr 15, 2025·0 cites·10 claims
- 3049US2009143786A1Implantable device with electrolytically detachable junction having multiple fine wires and method of introductionBOSTON SCIENT SCIMED INC·Filed 2008·Application pending·0 cites
- 3149US2009053299A1Methods for generating immune response using cationic-liposome-mediated nucleic acid deliveryUNIV GEORGETOWN·Filed 2008·Application pending·0 cites
- 3248US9480750B2Preparation of antibody or an antibody fragment targeted immunoliposomes for systemic administration of therapeutic or diagnostic agents and uses thereofUNIV GEORGETOWN·Filed 2015·Granted Nov 1, 2016·0 cites·12 claims
- 3348US2008306503A1Mechanically detachable vaso-occlusive deviceBOSTON SCIENT SCIMED INC·Filed 2007·Application pending·0 cites
- 3446US2005002998A1Method for improving stability and shelf-life of liposome complexesUNIV GEORGETOWN·Filed 2004·Application pending·0 cites
- 3543US2004241088A1Method for evaluating the efficacy of certain cancer treatmentsUNIV GEORGETOWN·Filed 2004·Application pending·0 cites
- 3627US2002051767A1Cancer treatmentFiled 1995·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Esther Chang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →